For almost a century, the American Society for Reproductive Medicine (ASRM) has been the global leader in multidisciplinary reproductive medicine research, ethical practice, and education. ASRM impacts reproductive care and science worldwide by creating funding opportunities for advancing reproduction research and discovery, by providing evidence-based education and public health information, and by advocating for reproductive health care professionals and the patients they serve. With members in more than 100 countries, the Society is headquartered in Washington, DC, with additional operations in Birmingham, AL. www.asrm.org
For media inquiries regarding this press release contact:
Riley Rogers
Public Relations Manager
Ph: 240-281-6552
E: rrogers@asrm.org
J. Benjamin Younger Office of Public Affairs
726 7th St. SE
Washington, DC 20003
Tel: (202) 863-2494
Press Releases
The News from ASRM
Latest News
An indispensable news digest for reproductive scientists, clinicians and allied health professionals. The Latest News posts are available to ASRM members in good standing only.
ASRM Announcements
ASRM Announcements contain information of interest to members about ASRM and its affiliates, NIH, FDA, WHO, or CDC matters.
ASRM Press Releases/Bulletins
ASRM Press Releases and Bulletins are published by ASRM's Office of Public Affairs to inform the press and Society members of important recent developments.
Legally Speaking Column
Legally Speaking is a column highlighting recent court decisions affecting the assisted reproductive technologies and the families they create, written by Susan L. Crockin, J.D. and guest authors who offer unique perspectives and expertise on significant legal topics.
Topic Resources
Ethical considerations for telemedical delivery of fertility care: an Ethics Committee opinion (2024)
Telemedicine has the potential to increase access to and decrease the cost of care. However, it also alters the nature of the physician-patient relationship and the interaction of patients with the healthcare system, which may limit access to care in some circumstances. Regardless of the modality of care delivery, the basic tenets of medical ethics and the obligations of physicians to their patients still hold. View the Ethics Committee OpinionJune 2023 ASRM Policy Briefing
Find out what the Office of Public Affairs has been doing to influence access to care and reproductive medicine legislation. View the webinar
ASRM’s Fertility and Sterility Publishes Series of Articles on Racial and Ethnic Disparities in Reproductive Medicine
"What these reports show is that we still have a lot of room for improvement in patient care and treatment of reproductive issues..." View the Press Release
Cross-border reproductive care: an Ethics Committee opinion (2022)
Cross-border reproductive care is a growing worldwide phenomenon, raising questions about why assisted reproductive technology patients travel for care, what harms and benefits may result, and what duties health care providers may have in advising and treating the patients who travel for reproductive services. View the Ethics Committee Document
Reproductive and infertility care in times of public health crises: an Ethics Committee opinion (2022)
Public health crises often require a framework shift in which patient autonomy is balanced with the need to safeguard the health of the community. During such crises, physicians should ensure that reproductive care is not unfairly curtailed. View the Committee opinion
Disparities in access to effective treatment for infertility in the United States: an Ethics Committee opinion (2021)
In the United States, economic, racial, ethnic, geographic, and other disparities prevent access to fertility treatment and affect treatment outcomes. View the Committee Opinion
Access to fertility treatment irrespective of marital status, sexual orientation, or gender identity: an Ethics Committee opinion (2021)
This statement explores the implications of reproduction by single individuals and unmarried couples and pertains to diverse sexuality and gender (DSG) or cisgender heterosexual persons. The statement concludes that individuals and couples should have access to fertility services irrespective of marital status, sexual orientation, or gender identity. View the Committee Opinion
